DOCSLIB.ORG

2018 Rice County Reportable Diseases

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2018 Rice County Reportable Diseases Rice County Reportable Infectious Disease Annual Table, 2018 Minnesota Department of Health County SE MN 10 Yr. Average IR Disease Incidence IR PY IR Incidence IR Incidence IR County SE MN Sexually Transmitted Disease 224 2,380 32,368 AIDS 0 0 0 5 1 116 2 2 2 3 Chancroid 0 0 0 0 0 0 0 0 0 0 Chlamydia 193 290 258 1,809 355 23,564 420 204 265 337 Gonorrhea 26 39 36 516 101 7,542 134 13 28 63 HIV 2 3 0 12 2 228 4 2 2 5 Syphilis (All Stages) 3 5 11 38 7 918 16 4 3 9 Enteric Infection 50 547 4,175 Amebiasis 1 2 0 5 1 59 1 1 1 2 Botulism (Foodborne) 0 0 0 0 0 0 0 0 0 0 Botulism (infant) 0 0 0 0 0 1 0 0 0 0 Campylobacteriosis 21 32 9 152 30 1,238 22 14 25 18 Cryptosporidiosis 4 6 5 133 26 532 9 2 16 7 Cyclosporiasis 0 0 0 50 10 156 3 0 0 0 E. coli O157* 0 0 0 12 2 115 2 5 4 2 Giardiasis 5 8 17 46 9 508 9 12 11 13 Hemolytic Uremic Syndrome 0 0 0 1 0 11 0 0 0 0 Listeriosis 0 0 0 1 0 9 0 0 0 0 Salmonellosis 14 21 5 86 17 1,009 18 11 13 14 Shigellosis 1 2 2 6 1 146 3 2 1 4 STEC (excluding O157)* 3 5 2 32 6 270 5 3 4 3 Trichinosis 0 0 0 0 0 0 0 0 0 0 Typhoid Fever 0 0 0 0 0 5 0 0 0 0 Vibrio (Including Vibrio Cholerae) 0 0 0 5 1 40 1 0 0 0 Yersiniosis 1 2 0 18 4 76 1 0 1 1 Vaccine Preventable Disease 29 319 3,228 Diphtheria 0 0 0 0 0 0 0 0 0 0 Influenza (Hospitalizations By Season) 25 38 96 239 47 2,490 44 29 45 45 Measles 0 0 0 0 0 2 0 0 0 0 Mumps 0 0 2 2 0 13 0 1 0 0 Pertussis 2 3 9 58 11 397 7 13 29 23 Polio (Paralytic) 0 0 0 0 0 0 0 0 0 0 Rubella 0 0 0 0 0 0 0 0 0 0 Tetanus 0 0 0 0 0 1 0 0 0 0 Varicella* 2 3 17 20 4 325 6 10 6 7 Vectorborne Infection 14 133 1,729 Anaplasmosis 2 3 3 29 6 496 9 2 6 10 Anaplasmosis-Ehrlichiosis (undetermined) 1 2 0 12 2 40 1 0 0 0 Babesiosis 2 3 2 8 2 49 1 0 1 1 Cache Valley Virus 0 0 0 0 0 0 0 0 0 0 Chikungunya* 0 0 0 0 0 7 0 0 0 0 Dengue Fever* 1 2 0 1 0 13 0 0 0 0 Ehrlichia chaffeensis 0 0 0 6 1 11 0 0 0 0 Ehrlichia ewingii 0 0 0 0 0 0 0 0 0 0 Ehrlichia muriseauclairensis* 0 0 0 1 0 7 0 0 0 0 Jamestown Canyon* 0 0 0 1 0 11 0 0 0 0 La Crosse Virus 0 0 0 0 0 0 0 0 0 0 Lyme Disease 6 9 8 67 13 950 17 7 19 22 Malaria (Includes Non-Mn Residents) 0 0 0 4 1 59 1 0 1 1 Powassan 0 0 0 0 0 3 0 0 0 0 Rocky Mountain Spotted Fever* 0 0 0 1 0 17 0 0 0 0 IR = Annual Incidence Rate (per 100,000) 10 Yr. Average IR= Average Annual Incidence Rate from 2008 to 2017 PY IR = Previous Year Annual Incidence Rate (per 100,000) *10 Yr. Average is less than 10 yrs. 1 County SE MN 10 Yr. Average IR Disease Incidence IR PY IR Incidence IR Incidence IR County SE MN Tularemia 0 0 0 0 0 2 0 0 0 0 Typhus Fever (Fleaborne Murine) 0 0 0 0 0 0 0 0 0 0 West Nile Fever 2 3 0 3 1 63 1 0 0 1 Zika Virus* 0 0 0 0 0 1 0 2 0 1 Invasive Infection 12 152 1,564 Haemophilus influenza 1 2 2 8 2 102 2 2 2 2 Neonatal Sepsis* 0 0 0 2 0 38 1 1 0 1 Streptococcus Group A (Invasive) 3 5 12 47 9 367 7 6 5 4 Streptococcus Group B (Invasive) 5 8 15 53 10 579 10 8 10 10 Streptococcus Pneumoniae 3 5 9 42 8 478 9 8 8 8 Meningitis 6 53 363 Meningitis (Aseptic, Includes Viral) 5 8 5 42 8 340 6 4 8 6 Meningitis (Neisseria Meningitidis) 0 0 2 0 0 0 0 0 0 0 Meningitis (Non-Neisseria Meningitidis Bacterium) 1 2 0 11 2 23 0 0 1 0 Fungal Infection 4 26 242 Blastomycosis* 1 2 0 6 1 58 1 1 1 1 Histoplasmosis* 3 5 5 20 4 184 3 3 4 4 Hepatitis 1 5 92 Hepatitis A 0 0 0 1 0 16 0 0 1 1 Hepatitis B (Non-perinatal) 0 0 0 1 0 16 0 0 0 0 Hepatitis B (Perinatal) 0 0 0 0 0 0 0 0 0 0 Hepatitis C 1 2 0 3 1 60 1 0 0 1 Mycobacterium Infection 1 17 173 Hansen's Disease 0 0 0 1 0 1 0 0 0 0 Tuberculosis 1 2 2 16 3 172 3 3 3 3 Zoonotic Infection 0 4 53 Brucellosis 0 0 0 0 0 2 0 0 0 0 Plague 0 0 0 0 0 0 0 0 0 0 Q Fever (Acute) 0 0 0 1 0 2 0 0 0 0 Q Fever (Chronic)* 0 0 0 0 0 2 0 0 0 0 Rabies (Animal) 0 0 0 3 1 32 1 1 1 1 Rabies (Human) 0 0 0 0 0 0 0 0 0 0 Toxoplasmosis 0 0 0 0 0 15 0 0 0 0 Other 0 18 174 Kawasaki Disease 0 0 2 2 0 22 0 1 1 1 Legionellosis 0 0 2 16 3 152 3 0 1 1 Grand Total 341 3,654 44,161 IR = Annual Incidence Rate (per 100,000) 10 Yr. Average IR= Average Annual Incidence Rate from 2008 to 2017 PY IR = Previous Year Annual Incidence Rate (per 100,000) *10 Yr. Average is less than 10 yrs. 2.
Load more

Recommended publications
  • Official Nh Dhhs Health Alert
    THIS IS AN OFFICIAL NH DHHS HEALTH ALERT Distributed by the NH Health Alert Network [email protected] May 18, 2018, 1300 EDT (1:00 PM EDT) NH-HAN 20180518 Tickborne Diseases in New Hampshire Key Points and Recommendations: 1. Blacklegged ticks transmit at least five different infections in New Hampshire (NH): Lyme disease, Anaplasma, Babesia, Powassan virus, and Borrelia miyamotoi. 2. NH has one of the highest rates of Lyme disease in the nation, and 50-60% of blacklegged ticks sampled from across NH have been found to be infected with Borrelia burgdorferi, the bacterium that causes Lyme disease. 3. NH has experienced a significant increase in human cases of anaplasmosis, with cases more than doubling from 2016 to 2017. The reason for the increase is unknown at this time. 4. The number of new cases of babesiosis also increased in 2017; because Babesia can be transmitted through blood transfusions in addition to tick bites, providers should ask patients with suspected babesiosis whether they have donated blood or received a blood transfusion. 5. Powassan is a newer tickborne disease which has been identified in three NH residents during past seasons in 2013, 2016 and 2017. While uncommon, Powassan can cause a debilitating neurological illness, so providers should maintain an index of suspicion for patients presenting with an unexplained meningoencephalitis. 6. Borrelia miyamotoi infection usually presents with a nonspecific febrile illness similar to other tickborne diseases like anaplasmosis, and has recently been identified in one NH resident. Tests for Lyme disease do not reliably detect Borrelia miyamotoi, so providers should consider specific testing for Borrelia miyamotoi (see Attachment 1) and other pathogens if testing for Lyme disease is negative but a tickborne disease is still suspected.
    [Show full text]
  • Parinaud's Oculoglandular Syndrome
    Tropical Medicine and Infectious Disease Case Report Parinaud’s Oculoglandular Syndrome: A Case in an Adult with Flea-Borne Typhus and a Review M. Kevin Dixon 1, Christopher L. Dayton 2 and Gregory M. Anstead 3,4,* 1 Baylor Scott & White Clinic, 800 Scott & White Drive, College Station, TX 77845, USA; [email protected] 2 Division of Critical Care, Department of Medicine, University of Texas Health, San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA; [email protected] 3 Medical Service, South Texas Veterans Health Care System, San Antonio, TX 78229, USA 4 Division of Infectious Diseases, Department of Medicine, University of Texas Health, San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA * Correspondence: [email protected]; Tel.: +1-210-567-4666; Fax: +1-210-567-4670 Received: 7 June 2020; Accepted: 24 July 2020; Published: 29 July 2020 Abstract: Parinaud’s oculoglandular syndrome (POGS) is defined as unilateral granulomatous conjunctivitis and facial lymphadenopathy. The aims of the current study are to describe a case of POGS with uveitis due to flea-borne typhus (FBT) and to present a diagnostic and therapeutic approach to POGS. The patient, a 38-year old man, presented with persistent unilateral eye pain, fever, rash, preauricular and submandibular lymphadenopathy, and laboratory findings of FBT: hyponatremia, elevated transaminase and lactate dehydrogenase levels, thrombocytopenia, and hypoalbuminemia. His condition rapidly improved after starting doxycycline. Soon after hospitalization, he was diagnosed with uveitis, which responded to topical prednisolone. To derive a diagnostic and empiric therapeutic approach to POGS, we reviewed the cases of POGS from its various causes since 1976 to discern epidemiologic clues and determine successful diagnostic techniques and therapies; we found multiple cases due to cat scratch disease (CSD; due to Bartonella henselae) (twelve), tularemia (ten), sporotrichosis (three), Rickettsia conorii (three), R.
    [Show full text]
  • Reportable Diseases and Conditions
    KINGS COUNTY DEPARTMENT of PUBLIC HEALTH 330 CAMPUS DRIVE, HANFORD, CA 93230 REPORTABLE DISEASES AND CONDITIONS Title 17, California Code of Regulations, §2500, requires that known or suspected cases of any of the diseases or conditions listed below are to be reported to the local health jurisdiction within the specified time frame: REPORT IMMEDIATELY BY PHONE During Business Hours: (559) 852-2579 After Hours: (559) 852-2720 for Immediate Reportable Disease and Conditions Anthrax Escherichia coli: Shiga Toxin producing (STEC), Rabies (Specify Human or Animal) Botulism (Specify Infant, Foodborne, Wound, Other) including E. coli O157:H7 Scrombroid Fish Poisoning Brucellosis, Human Flavivirus Infection of Undetermined Species Shiga Toxin (Detected in Feces) Cholera Foodborne Disease (2 or More Cases) Smallpox (Variola) Ciguatera Fish Poisoning Hemolytic Uremic Syndrome Tularemia, human Dengue Virus Infection Influenza, Novel Strains, Human Viral Hemorrhagic Fever (Crimean-Congo, Ebola, Diphtheria Measles (Rubeola) Lassa, and Marburg Viruses) Domonic Acid Poisoning (Amnesic Shellfish Meningococcal Infections Yellow Fever Poisoning) Novel Virus Infection with Pandemic Potential Zika Virus Infection Paralytic Shellfish Poisoning Plague (Specify Human or Animal) Immediately report the occurrence of any unusual disease OR outbreaks of any disease. REPORT BY PHONE, FAX, MAIL WITHIN ONE (1) WORKING DAY Phone: (559) 852-2579 Fax: (559) 589-0482 Mail: 330 Campus Drive, Hanford 93230 Conditions may also be reported electronically via the California
    [Show full text]
  • 2012 Case Definitions Infectious Disease
    Arizona Department of Health Services Case Definitions for Reportable Communicable Morbidities 2012 TABLE OF CONTENTS Definition of Terms Used in Case Classification .......................................................................................................... 6 Definition of Bi-national Case ............................................................................................................................................. 7 ------------------------------------------------------------------------------------------------------- ............................................... 7 AMEBIASIS ............................................................................................................................................................................. 8 ANTHRAX (β) ......................................................................................................................................................................... 9 ASEPTIC MENINGITIS (viral) ......................................................................................................................................... 11 BASIDIOBOLOMYCOSIS ................................................................................................................................................. 12 BOTULISM, FOODBORNE (β) ....................................................................................................................................... 13 BOTULISM, INFANT (β) ...................................................................................................................................................
    [Show full text]
  • Sexually Transmitted Diseases/Infections Chancroid
    Sexually Transmitted Diseases/Infections Chancroid Chancroid is a bacterial infection caused by Haemophilus ducreyi. It is spread by sexual contact and results in genital ulcers. Chancroid is a reportable genital ulcer condition that is rarely seen in North Carolina. When infection does occur, it is usually associated with sporadic outbreaks. Chancroid, as well as genital herpes and syphilis, is a risk factor in the transmission of HIV infection. Chancroid lesions may be difficult to distinguish from ulcers caused by genital herpes or syphilis. A physician must therefore diagnose the infection by excluding other diseases with similar symptoms. The combination of a painful genital ulcer and tender suppurative inguinal adenopathy suggests the diagnosis of chancroid. A probable diagnosis of chancroid, for both clinical and surveillance purposes, can be made if all of the following criteria are met: 1) the patient has one or more painful genital ulcers; 2) the patient has no evidence of T. pallidum infection by darkfield examination of ulcer exudate or by a serologic test for syphilis performed at least 7 days after onset of ulcers; 3) the clinical presentation, appearance of genital ulcers and, if present, regional lymphadenopathy are typical for chancroid; and 4) a test for HSV performed on the ulcer exudate is negative. A definitive diagnosis of chancroid requires the identification of H. ducreyi on special culture media that is not widely available from commercial sources; even when these media are used, sensitivity is less than 80 percent. No FDA- cleared PCR test for H. ducreyi is available in the United States, but such testing can be performed by clinical laboratories that have developed their own PCR test and have conducted a CLIA verification study.
    [Show full text]
  • Reportable Disease Surveillance in Virginia, 2013
    Reportable Disease Surveillance in Virginia, 2013 Marissa J. Levine, MD, MPH State Health Commissioner Report Production Team: Division of Surveillance and Investigation, Division of Disease Prevention, Division of Environmental Epidemiology, and Division of Immunization Virginia Department of Health Post Office Box 2448 Richmond, Virginia 23218 www.vdh.virginia.gov ACKNOWLEDGEMENT In addition to the employees of the work units listed below, the Office of Epidemiology would like to acknowledge the contributions of all those engaged in disease surveillance and control activities across the state throughout the year. We appreciate the commitment to public health of all epidemiology staff in local and district health departments and the Regional and Central Offices, as well as the conscientious work of nurses, environmental health specialists, infection preventionists, physicians, laboratory staff, and administrators. These persons report or manage disease surveillance data on an ongoing basis and diligently strive to control morbidity in Virginia. This report would not be possible without the efforts of all those who collect and follow up on morbidity reports. Divisions in the Virginia Department of Health Office of Epidemiology Disease Prevention Telephone: 804-864-7964 Environmental Epidemiology Telephone: 804-864-8182 Immunization Telephone: 804-864-8055 Surveillance and Investigation Telephone: 804-864-8141 TABLE OF CONTENTS INTRODUCTION Introduction ......................................................................................................................................1
    [Show full text]
  • Know Your Abcs: a Quick Guide to Reportable Infectious Diseases in Ohio
    Know Your ABCs: A Quick Guide to Reportable Infectious Diseases in Ohio From the Ohio Administrative Code Chapter 3701-3; Effective August 1, 2019 Class A: Diseases of major public health concern because of the severity of disease or potential for epidemic spread – report immediately via telephone upon recognition that a case, a suspected case, or a positive laboratory result exists. • Anthrax • Measles • Rubella (not congenital) • Viral hemorrhagic fever • Botulism, foodborne • Meningococcal disease • Severe acute respiratory (VHF), including Ebola virus • Cholera • Middle East Respiratory syndrome (SARS) disease, Lassa fever, Marburg • Diphtheria Syndrome (MERS) • Smallpox hemorrhagic fever, and • Influenza A – novel virus • Plague • Tularemia Crimean-Congo hemorrhagic infection • Rabies, human fever Any unexpected pattern of cases, suspected cases, deaths or increased incidence of any other disease of major public health concern, because of the severity of disease or potential for epidemic spread, which may indicate a newly recognized infectious agent, outbreak, epidemic, related public health hazard or act of bioterrorism. Class B: Disease of public health concern needing timely response because of potential for epidemic spread – report by the end of the next business day after the existence of a case, a suspected case, or a positive laboratory result is known. • Amebiasis • Carbapenemase-producing • Hepatitis B (perinatal) • Salmonellosis • Arboviral neuroinvasive and carbapenem-resistant • Hepatitis C (non-perinatal) • Shigellosis
    [Show full text]
  • Early History of Infectious Disease 
    © Jones and Bartlett Publishers. NOT FOR SALE OR DISTRIBUTION CHAPTER ONE EARLY HISTORY OF INFECTIOUS 1 DISEASE Kenrad E. Nelson, Carolyn F. Williams Epidemics of infectious diseases have been documented throughout history. In ancient Greece and Egypt accounts describe epidemics of smallpox, leprosy, tuberculosis, meningococcal infections, and diphtheria.1 The morbidity and mortality of infectious diseases profoundly shaped politics, commerce, and culture. In epidemics, none were spared. Smallpox likely disfigured and killed Ramses V in 1157 BCE, although his mummy has a significant head wound as well.2 At times political upheavals exasperated the spread of disease. The Spartan wars caused massive dislocation of Greeks into Athens triggering the Athens epidemic of 430–427 BCE that killed up to one half of the population of ancient Athens.3 Thucydides’ vivid descriptions of this epidemic make clear its political and cultural impact, as well as the clinical details of the epidemic.4 Several modern epidemiologists have hypothesized on the causative agent. Langmuir et al.,5 favor a combined influenza and toxin-producing staphylococcus epidemic, while Morrens and Chu suggest Rift Valley Fever.6 A third researcher, Holladay believes the agent no longer exists.7 From the earliest times, man has sought to understand the natural forces and risk factors affecting the patterns of illness and death in society. These theories have evolved as our understanding of the natural world has advanced, sometimes slowly, sometimes, when there are profound break- throughs, with incredible speed. Remarkably, advances in knowledge and changes in theory have not always proceeded in synchrony. Although wrong theories or knowledge have hindered advances in understanding, there are also examples of great creativity when scientists have successfully pursued their theories beyond the knowledge of the time.
    [Show full text]
  • Communicable Diseases Weekly Report
    Communicable Diseases Weekly Report Week 08, 21 February to 27 February 2021 In summary, we report: • Chancroid – one new case in a returned traveller • Rodent-borne disease risks • Novel coronavirus 2019 (COVID-19) • Summary of notifiable conditions activity in NSW For further information see NSW Health infectious diseases page. This includes links to other NSW Health infectious disease surveillance reports and a diseases data page for a range of notifiable infectious diseases. Chancroid One case of chancroid was notified this reporting week in a traveller returning from overseas. Chancroid is an acute sexually transmitted bacterial infection that causes painful genital ulcers. The condition is now rarely seen in Australia and only one other case has been notified in NSW during the past decade. Although the incidence of chancroid is decreasing globally, it is still reported in some regions within Africa, Asia, the Caribbean and South Pacific. Chancroid genital ulcer disease is a known risk factor for the transmission of HIV. The bacterium that causes chancroid, Haemophilus ducreyi, is usually transmitted through anal, oral, or vaginal sex with an infected person. After infection, one or more ulcers (sores) develop on the genitals or around the anus. Non-genital skin infections have also been reported globally, through non-sexual skin-to-skin contact with an infected person. The ulcers are usually painful, but rarely can be asymptomatic. Swelling in the groin (due to enlarged painful lymph nodes that can liquify and develop into buboes) can also occur. Other symptoms may include pain during sexual intercourse or while urinating. An infected person can spread the infection from their genital region to other parts of their body.
    [Show full text]
  • Annual Summary of Communicable Disease Reported to MDH, 2003
    MINNESOTA DEPARTMENT OF HEALTH DISEASE CONTROL N EWSLETTER Volume 32, Number 4 (pages 33-52) July/August 2004 Annual Summary of Communicable Diseases Reported to the Minnesota Department of Health, 2003 Introduction Minnesota Government Data Practices do not appear in Table 2 because the Assessment is a core public health Act (Section 13.38). Provisions of the influenza surveillance system is based function. Surveillance for communi- Health Insurance Portability and on reported outbreaks rather than on cable diseases is one type of ongoing Accountability Act (HIPAA) allow for individual cases. assessment activity. Epidemiologic routine communicable disease report- surveillance is the systematic collec- ing without patient authorization. Incidence rates in this report were tion, analysis, and dissemination of calculated using disease-specific health data for the planning, implemen- Since April 1995, MDH has participated numerator data collected by MDH and a tation, and evaluation of public health as one of the Emerging Infections standardized set of denominator data programs. The Minnesota Department Program (EIP) sites funded by the derived from U.S. Census data. of Health (MDH) collects disease Centers for Disease Control and Disease incidence may be categorized surveillance information on certain Prevention (CDC) and, through this as occurring within the seven-county communicable diseases for the program, has implemented active Twin Cities metropolitan area (Twin purposes of determining disease hospital- and laboratory-based surveil- Cities metropolitan area) or outside of it impact, assessing trends in disease lance for several conditions, including (Greater Minnesota). occurrence, characterizing affected selected invasive bacterial diseases populations, prioritizing disease control and food-borne diseases. Anaplasmosis efforts, and evaluating disease preven- Human anaplasmosis (HA) is the new tion strategies.
    [Show full text]
  • Disease Control Newsletter, July/August 2005
    MINNESOTA DEPARTMENT OF HEALTH D ISEASE C ONTROL N EWSLETTER Volume 33, Number 4 (pages 37-56) July/August 2005 Annual Summary of Communicable Diseases Reported to the Minnesota Department of Health, 2004 Introduction private and protected under the Incidence rates in this report were Assessment is a core public health Minnesota Government Data Practices calculated using disease-specific function. Surveillance for communi­ Act (Section 13.38). Provisions of the numerator data collected by MDH and a cable diseases is one type of assess­ Health Insurance Portability and standardized set of denominator data ment. Epidemiologic surveillance is the Accountability Act (HIPAA) allow for derived from U.S. Census data. systematic collection, analysis, and routine communicable disease report­ Disease incidence may be categorized dissemination of health data for the ing without patient authorization. as occurring within the seven-county planning, implementation, and evalua­ Twin Cities metropolitan area or outside tion of health programs. The Minnesota Since April 1995, MDH has participated of it (Greater Minnesota). Department of Health (MDH) collects as an Emerging Infections Program information on certain communicable (EIP) site funded by the Centers for Anaplasmosis diseases for the purposes of determin­ Disease Control and Prevention (CDC) Human anaplasmosis (HA) is the new ing disease impact, assessing trends in and, through this program, has imple­ nomenclature for the disease formerly disease occurrence, characterizing mented active hospital- and laboratory- known as human granulocytic affected populations, prioritizing control based surveillance for several condi­ ehrlichiosis. HA (caused by the efforts, and evaluating prevention tions, including selected invasive rickettsia Anaplasma phagocytophilum) strategies. Prompt reporting allows bacterial diseases and food-borne is transmitted to humans by Ixodes outbreaks to be recognized in a timely diseases.
    [Show full text]
  • Monthly Reportable Diseases Summary
    Monthly Reportable Diseases Summary June 2021 The data in the Monthly Disease Reports are provisional, based on current reports in the Michigan Disease Surveillance System (MDSS) made by local public health departments. The MDSS is a dynamic, continually active system; counts of disease are constantly changing as cases are investigated, confirmed as cases, or ruled out as not meeting the case definition. Each Monthly Disease Report reflects this constant activity as the numbers may slightly fluctuate each month. Therefore, it should be kept in mind that numbers in the Monthly Disease Reports are NOT final and should be used only to generally monitor Ottawa County trends over time. Unknown, suspect, probable and confirmed cases of the reportable condition are included in the report. An updated report is published each month. Specific data requests and questions should be directed to the following: Compiled by Derick N. Chia, MPH Epidemiologist [email protected] We value your feedback. Please use this QR code or click on the link below to tell us what you think of this report: Link to Survey 12251 James Street Holland, MI 49424-9661 www.miottawa.org/healthdata June 2021 Reportable conditions that are italicized have an accompanying graph at the end of the monthly section. Cases Reported in Last 4 Months** Year Total Through June Year End Disease Group Reportable Condition Mar-21 Apr-21 May-21 Jun-21 2018 2019 2020 2021 2020 Foodborne Amebiasis - 1 - - - - - 1 - Botulism - Foodborne - - - - - - - - - Campylobacter 2 4 1 6 33 29 16 22
    [Show full text]